SCHEMBL6891446

SCHEMBL6891446

C[CH]OC(=O)Oc1ccc2c(c1)CCC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MAPT P10636 4/20 0.45
POLB P06746 4/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 6/20 0.43
RAB9A P51151 6/20 0.43
RXRA P19793 3/20 0.43
RXRB P28702 3/20 0.43
RXRG P48443 3/20 0.43
L3MBTL1 Q9Y468 4/20 0.42
ALDH1A1 P00352 3/20 0.42
STS P08842 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
HPGD P15428 2/20 0.40
ALOX12 P18054 1/20 0.40
PTGES O14684 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11653596 0.85 SMN1; SMN2 (0.58) SMN1; SMN2ALOX15TSHRHSD17B10MAPT
SCHEMBL6892404 0.84 SMN1; SMN2 (0.46) SMN1; SMN2ALOX15TSHRHSD17B10MAPT
SCHEMBL6890994 0.82 POLB (0.54) SMN1; SMN2ALOX15TSHRHSD17B10MAPT
SCHEMBL9719992 0.81 ALOX15 (0.59) SMN1; SMN2ALOX15TSHRHSD17B10MAPT
SCHEMBL6890990 0.80 SMN1; SMN2 (0.54) SMN1; SMN2ALOX15TSHRHSD17B10MAPT
SCHEMBL7336195 0.79 PPARG (0.53) SMN1; SMN2ALOX15TSHRHSD17B10MAPT
SCHEMBL3896033 0.78 SMN1; SMN2 (0.55) SMN1; SMN2ALOX15TSHRHSD17B10MAPT
SCHEMBL6891449 0.78 POLB (0.50) SMN1; SMN2ALOX15TSHRHSD17B10MAPT
SCHEMBL875632 0.76 ALOX15 (0.57) SMN1; SMN2ALOX15TSHRHSD17B10MAPT
SCHEMBL6892407 0.76 MAPT (0.49) SMN1; SMN2ALOX15TSHRHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6677331-B2 HAVING SUBSTITUTED IMIDAZO(5,1-B)THIAZOLE GROUP AT 2-POSITION; MICROBIOCIDES AGAINST BETA-LACTAMASE PRODUCING BACTERIA AND RESISTANT PSEUDOMONAS MEIJI SEIKA KAISHA, LTD. (JP) 2004-01-13 US disclosed
US-20030149016-A1 Novel carbapenem derivatives KANO YUKO (JP) 2003-08-07 US disclosed
EP-1101766-A1 NOVEL CARBAPENEM DERIVATIVES MEIJI SEIKA KAISHA LTD. (JP) 2001-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149016-A1 Novel carbapenem derivatives DPEP1, TMPRSS15, STK35 SMN1; SMN2 2954/4885ALOX15 2514/4885TSHR 4209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.